Levodopa-induced dyskinesias
β
Giovanni Fabbrini; Jonathan M. Brotchie; Francisco Grandas; Masahiro Nomoto; Chr
π
Article
π
2007
π
John Wiley and Sons
π
English
β 109 KB
## Abstract Levodopaβinduced dyskinesias (LID) are common and difficult to treat. This review focuses on three issues related to LID: clinical features, classification and rating, pathophysiology and pathogenesis, and management. The three primary clinical syndromes are OFFβperiod dystonia, peakβdo